University of Maryland College Park

steven-jay-rivkin-grant

Steven M Jay, Ph.D.

August 16, 2019

Steven M Jay, Ph.D.University of Maryland College ParkCollege Park, MD, United States Engineering HER3-targeted ovarian cancer therapy The presence of the HER3 protein on the surface of ovarian cancer cells is associated with worse survival outcomes; therefore, blocking the pro-cancer activity of the HER3 protein may improve survival. Dr. Jay’s lab has developed a new […]

Read More

The Rivkin Center Joins OCRA

Starting April 1, 2025, the Rivkin Center’s ovarian cancer research funding, global symposium and fundraising activities will continue under the leadership of Ovarian Cancer Research Alliance (OCRA).

Melissa Saul